Yurogen Biosystems

Yurogen Biosystems, located in the Greater Boston area, is a world-class biotechnology and biopharmaceutical hub. We are committed to producing high-quality antibodies and antibody-based products to meet the diverse needs of our customers. Our innovative platform—the SMabTM platform—can effectively develop monoclonal antibodies from various host animals, especially rabbits. Our state-of-the-art monoclonal antibody screening platform significantly shortens the screening process and generates high-affinity monoclonal antibodies with extensive diversity.